The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

NCT00082589 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive

Interventions

DRUG: Eplerenone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.